Goldenwell Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Apr '25 Apr 14, 2025	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Market Capitalization	20	6	29	-	-	-
Market Cap Growth	-20.00%	-80.14%	-	-	-	-
Enterprise Value	20	6	29	-	-	-
Last Close Price	0.20	0.06	0.29	-	-	-
PS Ratio	35547.58	2479.23	610.98	-	-	-
PB Ratio	-1029.16	68.47	144.85	-	-	-
P/TBV Ratio	-	68.47	144.85	-	-	-
EV/Sales Ratio	-	2474.14	610.38	-	-	-
Debt / Equity Ratio	-	-	0.13	0.16	-	-
Asset Turnover	0.00	0.01	0.14	0.05	-	-
Inventory Turnover	0.00	0.01	0.12	-	-	-
Quick Ratio	3.97	37.75	1.72	1.34	-	-
Current Ratio	149.78	161.74	8.29	2.59	-	-
Return on Equity (ROE)	-289.19%	-81.65%	-391.43%	-42.52%	-2.55%	-
Return on Assets (ROA)	-42.57%	-30.67%	-173.59%	-20.84%	-1.61%	-
Return on Capital (ROIC)	-180.74%	-46.88%	-213.60%	-24.72%	-1.61%	-
Earnings Yield	-0.63%	-2.02%	-3.37%	-	-	-
Buyback Yield / Dilution	3.82%	-	-5.60%	-12.80%	-6.26%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.